Our Global Operations

To develop, manufacture, and commercialize vaccines globally, Valneva maintains sites and affiliates in six countries.

A specialty vaccine company

Valneva’s registered office is located in Saint-Herblain (Nantes), France. Our vaccine production and R&D activities take place at our four main European sites, while we also maintain commercial offices in several locations in Europe, Canada and the U.S.

The Company’s administrative functions are mostly spread across Austria (Vienna), France (Nantes), Scotland (Livingston) and Sweden (Solna).Our pre-clinical and clinical R&D activities are centered in Austria and France.

The Company operates three manufacturing sites across Europe in Scotland, Sweden and Austria to meet its clinical and commercial needs which are licensed by several regulatory authorities. This manufacturing base provides a long-term and sustainable industrial network to supply commercial and clinical products.

Valneva’s manufacturing network has been operating and producing licensed vaccines for more than ten years. The two main manufacturing sites in Scotland and Sweden have recently been expanded with state-of-the-art manufacturing facilities.

Our commercial teams are based in Austria (Vienna), Canada (Montreal), France (Lyon), Sweden (Solna), the United Kingdom (Fleet), and the United States (Bethesda).